Clinical Trials Logo

Clinical Trial Summary

This is a single institution study enrolling women over age 25 with newly diagnosed breast cancer and for whom a breast MR has been ordered as standard of care. Subjects will undergo a hybrid dedicated Breast PET/MRI in lieu of a breast MRI alone, for evaluation of extent of disease prior to surgical and oncologic management. The study will investigate any incremental added benefit to breast MRI specificity by the addition of concurrent hybrid breast PET.


Clinical Trial Description

The study hypothesis is that the combination of Breast PET/MRI, will improve specificity and decrease the number of false positive breast biopsies recommended based on breast MRI findings. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03510988
Study type Interventional
Source Weill Medical College of Cornell University
Contact
Status Terminated
Phase N/A
Start date March 15, 2018
Completion date March 4, 2022

See also
  Status Clinical Trial Phase
Terminated NCT01176838 - A 5 Year Follow-up on Newly Diagnosed Breast Cancer Patients N/A
Completed NCT01722851 - Circulating miRNAs.
Recruiting NCT01064427 - Factors Correlated With Fatigue in Breast Cancer N/A